2008 NSTI Nanotechnology Conference and Trade Show - Nanotech 2008 - 11th Annual
Technical Conferences
Merck Corporate Needs
NanoInk Symposium
Nano Electronics & Photonics
Nano Fabrication
MEMS & NEMS
Sensors & Systems
Micro & Nano Fluidics
MSM - Modeling Microsystems
WCM - Compact Modeling
Nanostructured Materials & Devices
Soft Nanotechnologies & Applications
Nanoparticles in Soft Materials - Colloidal Systems
Polymer Nanotechnology
Carbon Nano Structures & Devices
Nano Particles & Applications
Composites
Nanostructured Surfaces and Interfaces
Nanoscale Characterization
Energy Technologies & Applications
Nanotech in Health, Environment & Society
ICCN - Nanoscale Modeling
Nanoreliability
Bio Nano Materials & Tissues
Bio Sensors & Diagnostics
Biomarkers & Nanoparticles
Cancer Diagnostics, Imaging & Treatment
Drug Delivery & Therapeutics
Nano Medicine
Nanotech to Neurology
Phage Nanobiotechnology
Clean Technology 2008
Industrial Impact Workshop
Confirmed Speakers
Program Committee
Reviewers

Partnering Events:

TechConnect Summit
Clean Technology 2008

Molecular Imaging in Cancer

Anna Moore

Anna Moore

Associate Professor in Radiology at Harvard Medical School
Assistant in Cell Biology at Massachusetts General Hospital
Department of Radiology, MGH

Dr. Moore received her Ph.D. in Bioorganic Chemistry from the Russian Academy of Sciences and came to the MGH in 1991. Her research interests have been focused primarily on the uptake and processing of targeted contrast agents for molecular imaging, first at the Center for Molecular Imaging Research at MGH and now at the Athinoula A. Martinos Center for Biomedical Imaging. She has been particularly interested in creating target-specific contrast agents that will be able to detect tumor tissue with high specificity and with low binding to other tissues using multimodal imaging. As her work progressed, Dr. Moore became interested in the application of these powerful molecular imaging detection tools to other health care issues. She began work aimed at the development of noninvasive target-specific molecular imaging probes for the detection of the early stages of Type 1 diabetes and non-invasive assessment of beta-cell mass. She has published several papers on molecular imaging in both cancer and diabetes in leading peer-reviewed journals and obtained multiple grant awards from NIH and private funds (American Diabetes Association, RSNA, Juvenile Diabetes Foundation). Dr. Moore is an Assistant Professor of Radiology and a head of a group studying molecular imaging approaches to non-invasive detection of pathogenic conditions as well as a response to therapeutic intervention. In her new position at the Athinoula A. Martinos Center for Biomedical Imaging, she hopes to apply molecular approaches to imaging pathologic and normal processes in the brain.

Speaking in the special symposium on Nanotechnology for Cancer Prevention, Diagnosis and Treatment.


View Confimed Speakers

← Back to Conferences & Symposia